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Abstract  
Aim: FOXL2 encodes a forkhead transcription factor which is selectively expressed in 
the mesenchyme of developing mouse eyelids and in the adult ovarian follicles.1) Recent 
studies have revealed that a somatic FOXL2 codon 134 mutation (c.402C>G, p.C134W) 
is a feature shared by over 94-97% of adult GCT, which suggests that is constitutes an 
early event in their pathogenesis.2)3)4)5)6) 
To assess whether FOXL2  p.C134W mutation may play a role in the 
development of human ovarian tumors in the Japanese, we investigated 
the FOXL2  codon 134 mutation and protein expression of inhibin-α ,  bone 
morphogenetic protein 2 (BMP2) and follistatin (FST) in Japanese 
patients with granulosa cell  tumor (GCT) of the ovary and other ovarian 
tumors.   
Methods:  The study was performed between 2009 and 2012 in around 
Nagoya, Japan. Enrolled subjects were women with granulosa cell  tumor 
of the ovary (GCT, n=46; 44 adult-type GCT and 2 juvenile-type GCT), 
surface epithelial-stromal ovarian cancer (n=63), germ cell  tumor (n=3) 
and others (n=2).We analyzed 114 tumor tissues from ovarian tumors, 
including 44 adult-type and 2 juvenile-type GCT of the ovary and 68 
ovarian tumors by DNA sequencing. Immunohistochemistry was also 
performed in the adult and juvenile GCT tissues by immunostaining 
inhibin-α ,  BMP2 and FST.  
Results:  We found the FOXL2  p.C134W mutation in 27 out of 44 (61.4%) 
adult-type GCT of the ovary, but none in other ovarian tumors. 
Histologically, all of the adult-type GCT sections were positive for 
inhibin-α ,  and the expression of BMP2 and FST was detected in 14 of 44 
(31.8%) and 0 of 47 (0%), respectively. No significant differences 
regarding the diagnosed age, preoperative serum CA125 levels, or BMP2 
immunopositivity between the FOXL2  p.C134W mutation-positive and 
mutation-negative were found in the adult-type GCT patients.  
Conclusion:  Our findings suggest that FOXL2 p.C134W 
mutation-positive adult-type GCT of the ovary may not be as prevalent in 
the Japanese as compared to the previous data. 
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